MedPath

Early Versus Late Intubation Trial in Physician Manned Emergency Medical Services

Not Applicable
Withdrawn
Conditions
Trauma
Craniocerebral Trauma
Unconsciousness
Intracerebral Hemorrhage
Seizures
Registration Number
NCT01730001
Lead Sponsor
Norwegian Air Ambulance Foundation
Brief Summary

This study looks at advanced airway management in critically ill or injured patients treated by physician manned emergency medical services, comparing early (on-scene) intubation to late (emergency department) intubation.

Detailed Description

The ELITE trial is a prospective randomized controlled trial (RCT) to compare competent EARLY-intubation to LATE-intubation in patients with on-scene Glasgow Coma Scale (GCS) \< 9 and short ambulance transport times (\< 20 min) to hospital.

The study aims to establish if advanced airway management with endotracheal intubation (ETI) in the field by specially trained Emergency Medical Services (EMS) physicians - compared to endotracheal intubation (ETI) performed by physicians in the emergency department in the same group - improves outcome in terms of 30-day mortality, degree of disability at discharge, complications and length of hospital stay, and neurologic outcome at 6 months.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Adult patients (> 18 years)
  • Initial GCS < 9 independent of cause.
  • Intact airway reflexes and no impending airway obstruction.
  • Located < 20 min ambulance transport time from nearest hospital emergency department.
Exclusion Criteria
  • Pediatric patients (under 18 years).
  • Primary cardiorespiratory arrest (of non-traumatic / medical cause).
  • Planned helicopter transport to hospital.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
30 days mortality after injury or illness.30 days after illness or injury

Dead or alive

Neurologic outcome at 6 months after injury or illness.6 months after illness or injury

Neurologic outcome will be assessed using glascow outcome scores (GOS-E)

Secondary Outcome Measures
NameTimeMethod
Prevalence of adverse effects like cardiovascular complications (e.g. bradycardia, hypotension, asystole), and respiratory complications (e.g. hypoxia, pneumothorax).up to 6 months after illness or injury
Intubation success rates and airway management complications for the entire cohort and for key subsetsup to 6 months after illness or injury
Length of hospital stay, complications and degree of disability at discharge.up to 6 months after illness or injury

Trial Locations

Locations (2)

Haukeland University Hospital

🇳🇴

Bergen, Norway

Norwegian Air Ambulance Foundation

🇳🇴

Drøbak, Norway

Haukeland University Hospital
🇳🇴Bergen, Norway
© Copyright 2025. All Rights Reserved by MedPath